MENU
HLUBF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
H. Lundbeck A/S (HLUBF) Ownership - Who owns H. Lundbeck A/S?
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products... Show more
Profile
Industry
N/A
Address
Ottiliavej 9
Phone
+45 36301311
Employees
5681
Web
https://www.lundbeck.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
5.86B
P/E Ratio
8.31
Total Cash
2.7B
Projected Growth
5.97
Total Debt
15.19B
Revenue
22.95B
Risk (Beta)
0.02
Dividend Yield
0.03
Total Cash/Share
2.72
Total Debt/Equity
N/A
Revenue/Share
3.72 USD as % of share price
Fundamentals
HLUBF
Capitalization
5.86B
P/E Ratio
8.31
Risk (Beta)
0.02
Dividend Yield
0.03
Total Cash
2.7B
Total Cash/Share
2.72
Total Debt
15.2B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
5.97
Revenue/Share (as % of the share price)
3.72%
Revenue
23B
ROE
N/A
Book Value
24.6B
P/B Ratio
1.20
Cash Flow
N/A
Earnings
3.32
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
996M
Current Ratio
1.56
Current Revenue Per Employee
1093859.60
Dividends Per Share - Security
0.95
EBITDA
4.25B
Float
N/A
Float - Current
N/A
Gross Income Margin
82.61
Revenue To Assets
7.14
Shares Held By Institutions
134M
Shares Outstanding - Current
992M
Total Liabilities
29.6B
Total Volume MTD
N/A
Value
1
Gain YTD
3.612
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsGeneric
Profile
Fundamentals
Details
Industry
N/A
Address
Ottiliavej 9
Phone
+45 36301311
Employees
5681
Web
https://www.lundbeck.com